LARC

Daré Bioscience Announces Grant Funding Installment to Support Further Development of Novel Contraceptive Technology DARE-LARC1

Retrieved on: 
Mardi, avril 23, 2024
FDA, LARC, Woman, Levonorgestrel, Software, Diabetes, Communication, Fertility, Birth, Osteoporosis, Obesity, Human, Patient, Electronics, DSM-IV codes, Condition, Investigational New Drug, Injection, Pharmaceutical industry

SAN DIEGO, April 23, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it will receive a payment of $1 million as the latest installment under a grant agreement to advance the development of Daré’s investigational contraceptive DARE-LARC1 through nonclinical proof of principle studies and other IND-enabling work to allow for the submission of an Investigational New Drug (IND) Application with the FDA, approval of which will be required to commence testing in humans. Under the terms of the grant agreement, Daré may receive a total of up to approximately $49 million to support nonclinical development of DARE-LARC1. To date, Daré has received payments totaling approximately $28.3 million. Additional payments are conditioned on the program meeting specified development and reporting milestones.

Key Points: 
  • Under the terms of the grant agreement, Daré may receive a total of up to approximately $49 million to support nonclinical development of DARE-LARC1.
  • Additional payments are conditioned on the program meeting specified development and reporting milestones.
  • “The DARE-LARC1 product candidate is one of a number of novel contraceptive technologies being developed by Daré,” said Sabrina Martucci Johnson, President and CEO of Daré Bioscience.
  • To support development opportunities outside of the reproductive health category, including diabetes, obesity, and other conditions requiring precise and prolonged treatment, Daré is exploring strategic discussions with potential industry partners.

Earth Day Blue Economy & Climate Action Pathways (BECAP) Conference Launches Groundbreaking Collaboration

Retrieved on: 
Lundi, avril 22, 2024
Human Resources, Environmental Issues, Environmental Health, Alternative Energy, Energy, Professional Services, University, Other Natural Resources, Environment, Sustainability, Education, Natural Resources, Green Technology, Climate Change, Dorado, Climate change, LARC, Kick-off, Climate, The Blue Economy, Robotics, Santa Monica College, Partnership, Aquaculture, Conference, SMC, Research, Curriculum, Vision 2030, Faculty, Los Angeles Harbor College, Blue economy, Workforce, California Community Colleges, Student, Unmanned underwater vehicle, Growth, OECD, West Los Angeles College, Nursing

Santa Monica College, in partnership with the California Community Colleges Chancellor’s Office, AltaSea, and their partners, hosted the inaugural Blue Economy & Climate Action Pathways (BECAP) Kickoff and Conference on Friday, April 19.

Key Points: 
  • Santa Monica College, in partnership with the California Community Colleges Chancellor’s Office, AltaSea, and their partners, hosted the inaugural Blue Economy & Climate Action Pathways (BECAP) Kickoff and Conference on Friday, April 19.
  • This visionary collaboration is the first of its kind between the consortia of 13 colleges for Blue Economy workforce development in Los Angeles.
  • Project partners include Los Angeles Regional Consortium (LARC), Los Angeles Economic Development Corporation (LAEDC), and the Center for Climate Futures.
  • By 2030, the Blue Economy is projected to more than double its contribution to global value added, reaching over $3 trillion.

What Women Can Do to Take Control of Their Reproductive Health & Rights Post-Roe, according to Mary Jane Minkin, M.D.

Retrieved on: 
Mercredi, avril 17, 2024
Women, FDA, Baby, Maternity, Convenience Store, Health, Consumer, Pharmaceutical, General Health, Retail, Education, Medroxyprogesterone acetate, Roe v. Wade, 7-Eleven, LARC, Misoprostol, Condom, Safety, Pregnancy, Woman, Cadence, Policy, Supreme court, OTC, Mini, Planned Parenthood, Mifepristone, Reproductive rights, Abortion, Uterus, Yale University, Arm, Birth, Parenthood, Reproductive Sciences, Long-acting reversible contraceptives, Confidentiality, Progesterone, Pharmacy, Birth control

Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale University, stresses the critical need for accessible contraception and reproductive health tools to prevent unintended pregnancies.

Key Points: 
  • Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology, and Reproductive Sciences at Yale University, stresses the critical need for accessible contraception and reproductive health tools to prevent unintended pregnancies.
  • "The rollback on reproductive rights makes it absolutely imperative that we prioritize comprehensive access to contraception," says Dr. Minkin.
  • "It's not just about preventing pregnancy; it's about preserving the autonomy and health of women across the nation."
  • "We must ensure that women of all ages have the education, resources, and confidentiality to make informed choices about their reproductive health.

Family Source Consultants Announces New Exclusive Partnership with Israel-Based Manor Baby

Retrieved on: 
Mardi, janvier 9, 2024
Dream, Family, FSC, Patient, Professional, Consultant, LGBTQ, Knowledge, Partnership, Mandarin Oriental Hotel Group, Optimism, LARC, Parent, Birth control

CHICAGO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- This month, Family Source Consultants (FSC), a surrogacy agency based in the United States, announced a new partnership with Manor Baby, Israel's leading surrogacy and egg donation company. Under the unique arrangement, FSC will work with a new fertility clinic partner, the California-based Los Angeles Reproductive Center (LARC), to provide exclusive, comprehensive surrogacy services for intended parents in Israel.

Key Points: 
  • CHICAGO, Jan. 9, 2024 /PRNewswire-PRWeb/ -- This month, Family Source Consultants (FSC), a surrogacy agency based in the United States, announced a new partnership with Manor Baby, Israel's leading surrogacy and egg donation company.
  • This new, exclusive partnership with Manor Baby and LARC will allow all three agencies to provide a "seamless, positive experience" for Israeli intended parents.
  • "Both Manor Baby and Family Source Consultants have a solid and well-established reputation in the field of egg donation and surrogacy, both locally and internationally."
  • This date brings more than this partnership to recognize as Family Source Consultants is also celebrating 17 years of bringing dreams and miracles together!

Daré Bioscience’s DARE-LARC1 Platform Technology Achieves Proof-of-Concept Device that has Transformative Potential for Women’s Health as well as in Treating a Broad Range of Diseases

Retrieved on: 
Jeudi, janvier 4, 2024
Levonorgestrel, LARC, Woman, IND, Software, FDA, Injection, Electronics, Diabetes, SAN, Fertility, DSM-IV codes, Osteoporosis, Obesity, Patient, Birth, Communication

This milestone reflects the drug delivery platform’s potential to address the treatment burden for various conditions where treatment requires frequent dosing or regular injections.

Key Points: 
  • This milestone reflects the drug delivery platform’s potential to address the treatment burden for various conditions where treatment requires frequent dosing or regular injections.
  • Daré is currently developing the platform technology internally with funding from a foundation grant in DARE-LARC1, a potential new class of long-acting, reversible contraceptive (LARC).
  • Key features of the implant technology include:
    Precision dosing: Unique design allows for precise dose timing and amount using individually addressable drug micro-reservoirs.
  • Smartphone integration: Platform can be paired with custom mobile apps designed for each application to create a personalized experience for the user.

Local Non-Profits Receive More than $288,000 in Grants to Advance Southern California Clean Energy Initiatives

Retrieved on: 
Samedi, décembre 2, 2023
Columbia Memorial Space Center, Carbon, STEM, Climate change, Organization, City, VUSD, Government Affairs Institute, CAG, Workforce, Science, Learning, Student, Virtual reality, Populus, Primary energy, Wind, Solar energy, Community benefits agreement, The Business Council, Health, University, USGBC, Friends, School, Partnership, CPA, VR, Certification, Ventura Unified School District, LARC, CCA, Education, Renewable energy, Nursing, Recycling, Tourism, Forestry, Los Angeles River, Paramount, Engineering

LOS ANGELES, Dec. 1, 2023 /PRNewswire-PRWeb/ -- Clean Power Alliance (CPA) and Calpine Energy Solutions have announced the latest group of awardees to receive funding through their annual Community Benefits Grant Program. Through this ongoing partnership, 12 non-profit organizations located throughout CPA's service territory in Los Angeles and Ventura counties will receive more than $288,000 in grants to advance clean energy, green job training, environmental education and stewardship, and energy equity and diversity efforts within their respective communities. Individual grants range from $20,000 to $30,000.

Key Points: 
  • Investing in local communities is a key aspect of CPA's mission to strengthen regional resilience and advance access to clean energy for all.
  • "The selected projects will benefit thousands of individuals and move us closer to a clean energy future."
  • Calpine Energy Solutions awards the program funding, while CPA develops the grant guidelines and helps recruit local non-profit organizations to apply for the funding.
  • "Calpine Energy Solutions is committed to our many CCA partners and the wide range of communities they serve," said Brock.

Natera to Present New Signatera™ MRD Data at ESMO 2023, Featuring Large, Updated Analysis from CIRCULATE-Japan Study

Retrieved on: 
Lundi, octobre 16, 2023
Other Health, Health, Genetics, Health Technology, Oncology, Congress, DFS, Neoplasm, Doctor of Philosophy, Hepatocellular carcinoma, NTRA, Nature Medicine, Abstract, LARC, Master of Science, RCC, DNA, Survival, CRC, Cancer, Recurrence, Disease, Renal cell carcinoma, Colorectal cancer, European Society for Medical Oncology, ESMO, AA, Pan-cancer analysis, ECD, MRD, Cohort (statistics), HCC, Patient, BTC, Pharmaceutical industry, Medical imaging, Aroma compound, MD, Natera

Natera and its collaborators will present MRD data in a total of seven abstracts, including a mini-oral and several poster presentations.

Key Points: 
  • Natera and its collaborators will present MRD data in a total of seven abstracts, including a mini-oral and several poster presentations.
  • Other presentations will highlight new Signatera data in rectal cancer, appendiceal adenocarcinoma, hepatocellular carcinoma, renal cell carcinoma, and other solid tumors.
  • “We look forward to the presentation of updated data from the landmark CIRCULATE-Japan study.
  • Presentation #1908P | Renal Cancer | Oct. 23 | Presenter: Michael Smigelski, MD
    This study demonstrates that longitudinal ctDNA monitoring may be predictive of recurrence-free survival post-surgery in patients with RCC.

Lunit and the Japan National Cancer Center Hospital East Partner in AI Pathology to Advance Precision Oncology

Retrieved on: 
Mardi, mai 30, 2023
Partnership, TIL, HER2, MSS, American Society of Clinical Oncology, Pathology, Cancer, Biomarker, H&E, PCR, Immunohistochemistry, ASCO, LARC, Patient, TME, AI, SCRUM, Chemoradiotherapy, CRT, Tumor microenvironment, PD-L1, Society, Medical device, Medical imaging

SEOUL, South Korea, May 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center Hospital East (NCCHE) to evaluate and validate its AI pathology solution for tissue data analysis.

Key Points: 
  • SEOUL, South Korea, May 30, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global provider of AI-powered cancer diagnostic solutions, today announced collaboration with the National Cancer Center Hospital East (NCCHE) to evaluate and validate its AI pathology solution for tissue data analysis.
  • Working with Lunit and the SCRUM project will bring a new approach to cancer treatment," said the principal investigator of SCRUM-Japan MONSTAR-SCREEN project, Dr. Takayuki Yoshino of the National Cancer Center Hospital East (Kashiwa City, Chiba Prefecture).
  • Lunit and NCCHE remain committed to conducting studies to further validate the findings and to explore AI analysis in additional treatment settings.
  • "We are delighted to partner with the National Cancer Center Hospital East in the validation of our Lunit SCOPE suite, marking a significant step towards advancing precision oncology and improving optimized patient treatment," said Brandon Suh, CEO of Lunit.

Lunit Demonstrates Predictive Value of AI-Biomarker Platform at the 2023 ASCO Annual Meeting

Retrieved on: 
Jeudi, mai 25, 2023
Abstract, Therapy, ICI, TIL, The Cancer Genome Atlas, TAA, Neoplasm, MSS, American Society of Clinical Oncology, Clinical trial, Pathology, Booth, Cancer, Lung cancer, Head, Research, NSCLC, Cell, Immunotherapy, PCR, ASCO, Publication, LARC, Collection, Patient, Data, AUC, TME, Annual general meeting, HNSCC, MET, Poster, Chemoradiotherapy, CRT, Tumor microenvironment, Society, TCGA, Neoadjuvant therapy, NCCE, Medical imaging

SEOUL, South Korea, May 25, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global leader of AI-powered cancer diagnostics and therapeutics solutions, is set to make a significant impact at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois. This year, Lunit will present 16 abstracts at the conference, showcasing the groundbreaking capabilities of its AI-biomarker platform, Lunit SCOPE. This comprehensive collection of studies includes 10 poster presentations and 6 online publications, covering a wide spectrum of topics. From predicting clinical outcomes to exploring the complex dynamics of tumor microenvironments, these advancements highlight Lunit's unwavering commitment to advancing AI pathology research and personalized cancer care.

Key Points: 
  • This year, Lunit will present 16 abstracts at the conference, showcasing the groundbreaking capabilities of its AI-biomarker platform, Lunit SCOPE.
  • This comprehensive collection of studies includes 10 poster presentations and 6 online publications, covering a wide spectrum of topics.
  • "I am excited to present the groundbreaking results from our studies at ASCO, showcasing the immense impact of the Lunit SCOPE suite," said Brandon Suh, CEO of Lunit.
  • "Through our AI-biomarker platform, we are paving the way to provide valuable insights into cancer progression, immune responses, and treatment efficacy.

Six Flags Appoints Angus Jenkins as Corporate Vice President of Maintenance and Engineering

Retrieved on: 
Vendredi, avril 21, 2023
Architecture, Commercial Building & Real Estate, Construction & Property, Building Systems, Theme Parks, Landscape, Other Construction & Property, Entertainment, Recreation, Engineering, Construction, Vekoma, LARC, Water, Safety, Aircraft Maintenance and Engineering Corporation, Amusement park, Maintenance

Six Flags Entertainment Corporation, the world’s largest regional theme park company and largest operator of water parks in North America, today announced the appointment of Angus Jenkins to the newly created role of Vice President, Maintenance and Engineering.

Key Points: 
  • Six Flags Entertainment Corporation, the world’s largest regional theme park company and largest operator of water parks in North America, today announced the appointment of Angus Jenkins to the newly created role of Vice President, Maintenance and Engineering.
  • Jenkins and a team of four regional directors will lead the combined Maintenance and Engineering Division, supporting Six Flags’ 27 properties with enhanced leadership, technical knowledge and on-going support.
  • “I am delighted to have Angus lead our Maintenance and Engineering team and believe this newly combined organization will allow us to elevate our industry leading safety standards while also improving ride up-times.”
    “I am thrilled to be leading the Maintenance and Engineering Division,” added Mr. Jenkins.
  • Prior to joining Six Flags in 2018, Jenkins worked with Chance Morgan Rides, Vekoma Rides, Leisure and Recreation Concepts, Inc. (LARC) and Alpha Smartparks.